Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

1 Aug 2018 07:00

RNS Number : 3749W
Barr(A.G.) PLC
01 August 2018
 

IMMEDIATE RELEASE 1 August 2018A.G. BARR p.l.c. 

("A.G. BARR")

Trading Update 

Revenue increased 5% in the period and Group on track to meet full year profit expectations

A.G. BARR, which produces and markets some of the UK's leading drink brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a trading update in respect of the 26 weeks ended 28 July 2018.

We are pleased to report continued strong sales momentum with revenue for the 26 weeks ended 28 July 2018 expected to be c.£136m, an increase of c.5% on the prior year (2017 : £129.8m*). This is especially positive given the 8.8% growth reported for the corresponding period in 2017.

The soft drinks market was up 4.5% in value terms and increased 1.4% in volume (source : IRI UK soft drinks market data from 28 January to 1 July 2018), recovering from the impact of severe weather in the first quarter and benefiting from hot early summer weather across the UK, along with the value increase associated with the implementation of the Soft Drinks Industry Levy (SDIL) in April.

Against this market backdrop our core brands have performed well. In the period we completed the implementation of our reformulation programme and have grown market share. The IRN-BRU brand in particular has continued its positive growth momentum, with regular IRN-BRU increasing its volume and value share of the total soft drinks market alongside strong growth in IRN-BRU XTRA.

We have continued to invest behind both our established brands and our innovation pipeline. In the period this has supported further significant growth in Rubicon Spring and the recent launch of Street Drinks by Rubicon. Our new partnership brands, San Benedetto and Bundaberg, have made encouraging early progress and Funkin continues to perform strongly across all channels.

Our balance sheet remains robust supported by strong cash generation and the share repurchase programme continued during the period.

Outlook

The external landscape remains volatile. In addition we have seen the implementation of the Soft Drinks Industry Levy, the market impact of which is still to be fully determined. During this period of uncertainty we will continue to invest behind our brands, innovation and people which, while having a moderate impact on margins in the current financial year, will support the delivery of our growth strategy.

Our full year profit expectations remain unchanged.

Roger White, Chief Executive Officer, commented :

"We have delivered strong top-line growth in a period of considerable marketplace volatility and change. Our growth across core brands is especially encouraging and our strong second half brand and sales development plans give us confidence that we can deliver against our profit expectations ."

For more information, please contact:

A.G. BARR 01236 852400 Instinctif Partners  020 7457 2020

 Roger White, Chief Executive Justine Warren

 Stuart Lorimer, Finance Director Matthew Smallwood

Next update : Interim Results - 25 September 2018

* Note : All numbers reflect the adoption of IFRS 15 "Revenue from Contracts with Customers". This has resulted in a £7.6m reclassification in net revenue in the period that would have previously been charged within overheads. There has been a £6.8m restatement to the prior year to enable an accurate comparison of performance. There will be no impact on profit before tax.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTWGUMAMUPRGAG
Date   Source Headline
10th Feb 20253:59 pmRNSDirector/PDMR Shareholding - Replacement
10th Feb 20253:10 pmRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSTrading Update
20th Jan 202511:00 amRNSDirector Declaration
9th Jan 20254:42 pmRNSDirector/PDMR Shareholding
7th Jan 202511:44 amRNSNotice of Trading Update
17th Dec 20249:20 amRNSDirector Declaration
9th Dec 20241:50 pmRNSDirector/PDMR Shareholding
12th Nov 20241:35 pmRNSDirector/PDMR Shareholding
4th Nov 202410:54 amRNSDirector/PDMR Shareholding
9th Oct 202410:10 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSInterim Results
9th Sep 20241:03 pmRNSDirector/PDMR Shareholding
4th Sep 20249:08 amRNSDirector Declaration
20th Aug 20248:39 amRNSDirector/PDMR Shareholding
8th Aug 20241:10 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTrading Statement
8th Jul 202412:03 pmRNSDirector/PDMR Shareholding
4th Jul 202410:17 amRNSNotice of Results
1st Jul 20244:50 pmRNSDirector/PDMR Shareholding
21st Jun 20243:22 pmRNSDirector/PDMR Shareholding
10th Jun 20241:51 pmRNSDirector/PDMR Shareholding
10th Jun 20241:48 pmRNSDirector/PDMR Shareholding
4th Jun 20249:36 amRNSDirector/PDMR Shareholding
31st May 20241:54 pmRNSResult of AGM
9th May 202411:28 amRNSDirector/PDMR Shareholding
7th May 20249:06 amRNSDirector/PDMR Shareholding
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.